CA2010275A1 - Antigenes de cellules des ilots pancreatiques obtenus par clonage moleculaire - Google Patents

Antigenes de cellules des ilots pancreatiques obtenus par clonage moleculaire

Info

Publication number
CA2010275A1
CA2010275A1 CA2010275A CA2010275A CA2010275A1 CA 2010275 A1 CA2010275 A1 CA 2010275A1 CA 2010275 A CA2010275 A CA 2010275A CA 2010275 A CA2010275 A CA 2010275A CA 2010275 A1 CA2010275 A1 CA 2010275A1
Authority
CA
Canada
Prior art keywords
iddm
cell antigens
pancreatic islet
islet cell
ica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2010275A
Other languages
English (en)
Other versions
CA2010275C (fr
Inventor
Daniel Rabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2010275A1 publication Critical patent/CA2010275A1/fr
Application granted granted Critical
Publication of CA2010275C publication Critical patent/CA2010275C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002010275A 1989-02-17 1990-02-16 Antigenes de cellules des ilots pancreatiques obtenus par clonage moleculaire Expired - Lifetime CA2010275C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US312,543 1989-02-17
US44170389A 1989-12-04 1989-12-04
US441,703 1989-12-04

Publications (2)

Publication Number Publication Date
CA2010275A1 true CA2010275A1 (fr) 1990-08-17
CA2010275C CA2010275C (fr) 2000-08-29

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010275A Expired - Lifetime CA2010275C (fr) 1989-02-17 1990-02-16 Antigenes de cellules des ilots pancreatiques obtenus par clonage moleculaire

Country Status (14)

Country Link
EP (1) EP0383129B1 (fr)
JP (1) JP2858467B2 (fr)
AT (1) ATE122394T1 (fr)
AU (1) AU626636B2 (fr)
CA (1) CA2010275C (fr)
DE (1) DE69019190T2 (fr)
DK (1) DK0383129T3 (fr)
ES (1) ES2072928T3 (fr)
FI (1) FI103730B1 (fr)
GR (1) GR3017019T3 (fr)
IE (1) IE66997B1 (fr)
IL (1) IL93397A (fr)
NO (1) NO306996B1 (fr)
PT (1) PT93166B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
WO1992004632A1 (fr) 1990-09-07 1992-03-19 The Regents Of The University Of California Procedes de diagnostic et de traitement de diabete
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
WO1992006105A1 (fr) * 1990-10-02 1992-04-16 Trigen Incorporated Anticorps et procedes de diagnostic et de traitement du diabete
JPH06508030A (ja) * 1991-05-15 1994-09-14 ザイモジェネティクス，インコーポレイティド ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
WO1993016725A1 (fr) * 1992-02-27 1993-09-02 The Board Of Trustees Of The Leland Stanford Junior University Antigene precoce pour diabete autoimmun
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
AU7159898A (en) * 1997-04-25 1998-11-24 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE53862T1 (de) * 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
WO1986007464A1 (fr) * 1985-06-14 1986-12-18 Genetic Systems Corporation Procedes d'identification d'alleles associes a un risque accru de diabete
CA1327162C (fr) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Methode de traitement prophylactique de personnes atteintes de maladies auto-immunes
EP0359783B2 (fr) * 1987-06-24 2002-04-17 Autoimmune, Inc. Traitement de maladies auto-immunitaires par administration orale d'auto-antigenes

Also Published As

Publication number Publication date
ATE122394T1 (de) 1995-05-15
FI103730B (fi) 1999-08-31
AU4988390A (en) 1990-08-23
NO900474L (no) 1990-08-20
EP0383129A2 (fr) 1990-08-22
EP0383129A3 (fr) 1991-07-31
NO900474D0 (no) 1990-02-01
IE66997B1 (en) 1996-02-21
DE69019190T2 (de) 1995-09-14
JPH0347133A (ja) 1991-02-28
ES2072928T3 (es) 1995-08-01
PT93166A (pt) 1990-08-31
DE69019190D1 (de) 1995-06-14
DK0383129T3 (da) 1995-10-09
PT93166B (pt) 1997-11-28
JP2858467B2 (ja) 1999-02-17
FI900759A0 (fi) 1990-02-15
CA2010275C (fr) 2000-08-29
IL93397A0 (en) 1990-11-29
GR3017019T3 (en) 1995-11-30
IL93397A (en) 1997-06-10
IE900589L (en) 1990-08-17
FI103730B1 (fi) 1999-08-31
NO306996B1 (no) 2000-01-24
EP0383129B1 (fr) 1995-05-10
AU626636B2 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
CA2010275A1 (fr) Antigenes de cellules des ilots pancreatiques obtenus par clonage moleculaire
IE940558L (en) Process for purifying recombinant proteins, and use of¹products thereof
CA2029861A1 (fr) Diagnostic et traitement du diabete sucre insulino-dependant
DE3671633D1 (en) Htlv iii polypeptide.
CA2143491A1 (fr) Nouveau peptide lie a l'apoptose humaine et adn codant ledit peptide
AU3192889A (en) T cell activation markers
AU6781990A (en) Toxoplasma gondii antigens, the preparation thereof and the use thereof
ZA891861B (en) Monoclonal antibodies
WO2000020587A3 (fr) Antigenes associes au cancer et leurs utilisations
DE69535719D1 (de) Fas-antigenbindender ligand
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
WO1996021734A3 (fr) Antigenes p15 et tyrosinase du melanome et leur utilisation dans des procedes diagnostiques et therapeutiques
WO2000036087A3 (fr) Marqueur autoantigenique des nucleoles pour la detection du lupus erythemateux aigu dissemine
EP0331356A3 (fr) Expression de protéines de fixant au VIH
WO1995019371A3 (fr) Expression de proteines de couches superficielles
EP0177814A3 (fr) Anticorps contre les peptides et leurs utilisation dans la détection des produits d'oncogènes
EP0293827A3 (fr) Essai pour leishmaniose
WO2003097814A3 (fr) Scytorivines et conjugues, proteines de fusion, acides nucleiques, vecteurs, cellules hotes, compositions et anticorps apparentes, et procedes d'utilisation de scytovirines
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
WO2000072021A3 (fr) Antigenes associes au cancer et utilisations correspondantes
WO2000020586A3 (fr) Antigenes associes au cancer du rein et leurs utilisations

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry